Search the Newsreel

Does Cellebrite DI’s Lowered 2026 Outlook and New CEO Reset Its AI Narrative (CLBT)?

In August 2026, Cellebrite DI Ltd. reported second-quarter results showing revenue of US$131.14 million and net income of US$6.37 million, while lowering its full-year 2026 revenue guidance to US$555 million–US$561 million and announcing Shiven Ramji's appointment as CEO, succeeding Thomas E. Hogan. The combination …

US Stock Market Today: S&P 500 Futures Edge Higher As Inflation Watch Intensifies

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Friday, Aug, 14 2026 US stock futures edge higher this morning, with E-mini S&P 500 …

ETFs Investing in Cellebrite DI Ltd. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Cellebrite DI Ltd. (CLBT), providing detailed information such as market value, weight, issuer, management style, expense ratio, AUM, price change, relative volume, and 3-year NAV total return for each fund. It aims …

Cerebras Systems (CBRS) Stock Sinks As Revenue Growth Meets Deepening Losses

Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

CBRS Archives

This page provides news and article archives for Cerebras Systems Inc. (CBRS), a company that designs AI processors. It includes financial data, recent stock performance following a Q2 2026 earnings miss, and a list of articles discussing the company's performance, analyst insights, and its …

Cellebrite (CLBT) CEO gets 339,484-share award and withholds 139,713 shares for taxes

Cellebrite DI Ltd. CEO Thomas E. Hogan received an award of 339,484 ordinary shares on August 11, 2026, after performance conditions from awards granted in September 2025 were met. Subsequently, 139,713 shares were withheld and sold on August 12, 2026, at a weighted average …

Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

Levi & Korsinsky, LLP has announced an investigation into Cellebrite DI Ltd. (CLBT) following a significant stock drop of over 30% after the company's Q2 2026 results. The investigation focuses on whether Cellebrite made misleading statements regarding its 2026 annual recurring revenue (ARR) and …

Cathie Wood Sells Palantir Stock After Blowout Earnings, Ark Invest Doubles Down on Cerebras Systems

Analysts’ Top NA Picks: Cerebras Systems, Inc. Class A (CBRS), AEVEX Corp. Class A (AVEX)

Cellebrite DI (CLBT) Names Shiven Ramji CEO As Revenue Guidance Is Cut

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Cellebrite DI (NasdaqGS: CLBT) announced a planned CEO transition, with Shiven Ramji set to succeed Thomas E. Hogan. Ramji joined Cellebrite DI earlier this year as President, …

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Platform Evolution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan Sells 139,713 Shares of Stock

Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan sold 139,713 shares of the company's stock for approximately $2.15 million, reducing his direct ownership by 15.02%. The sale comes as Cellebrite's stock fell, trading below its moving averages, and the company recently lowered its 2026 revenue and …

Cellebrite DI Ltd (CLBT) (Q2 2026) Earnings Call Highlights: ARR Misses Guidance, Full-Year ...

This article first appeared on GuruFocus. ARR: Increased 21% to $508 million, missing the bottom end of guidance. Revenue: $131 million, up 16% year-over-year. Subscription Revenue: $119.5 million, up 16%, representing 91% of total revenue. Gross Profit: Increased 16% to $112 million, with a …

Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance

Cerebras Stock PlummetsDespite Solid Earnings

Cerebras Systems stock has had a wild ride in a crowded field. Its stock was down despite a strong earnings report. Continue Reading

Jane Street Group (CBRS) discloses 5.1% Cerebras Systems ownership on Schedule 13G

Jane Street Group, LLC and its subsidiary Jane Street Capital, LLC have reported a beneficial ownership of 5.1% in Cerebras Systems Inc. This stake, totaling 5,222,522 shares of Class A common stock, grants them shared voting and dispositive power. The disclosure was made via …

Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply

Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)

Cellebrite DI Ltd. (CLBT) experienced a significant 33% stock drop post-earnings, which the author believes is an overreaction. Despite missing Q2 guidance for ARR and revenue growth, and facing management transition and slower Inseyets conversions, the company maintains strong core products, high retention, and …

Cellebrite DI Releases Q2 2026 Financial Results

Cellebrite DI Ltd. reported mixed Q2 2026 financial results, with earnings per share meeting expectations at $0.11, while revenue of $131.1M slightly missed the $131.9M estimate. Despite the revenue miss, the company showed strong year-over-year growth, with total revenue up 16.0% and subscription services …

Cerebras Stock Slumps After Earnings -- Analysts See 'Buying Opportunity'

This article first appeared on GuruFocus. Cerebras Systems (NASDAQ:CBRS) shares fell double digits on Thursday after the AI chipmaker's second-quarter report triggered a sharp pullback, even as several Wall Street firms maintained bullish views on the stock. Cerebras reported $180.1 million in second-quarter revenue, …

CBRS Q2 Earnings Beat Estimates as Cloud Revenues Surge 287%

Cerebras Systems CBRS reported a second-quarter 2026 loss of 4 cents per share, narrower than the Zacks Consensus Estimate, delivering an 80.95% earnings surprise. Core revenues of $209.87 million rose 103% year over year and topped the consensus estimate by 8.09%. The upside was …

Sandisk, Cisco, Micron, Ondas, Coherent, Cerebras, and More Stocks That Explain Today’s Market

Stocks rose Thursday following softer-than-expected wholesale inflation data for July and growing confidence that the Federal Reserve won’t raise interest rates. The company added that adjusted gross margins should stabilize at around 80% over that period, with an adjusted free-cash-flow margin of about 50%. …

Cerebras slumps after Q2 miss, but analysts remain positive, some see a buying opportunity

This article first appeared on GuruFocus. Cerebras Systems (NASDAQ:CBRS) shares fell double digits on Thursday after the AI chipmaker's second-quarter report triggered a sharp pullback, even as several Wall Street firms maintained bullish views on the stock. Cerebras reported $180.1 million in second-quarter revenue, …

Cellebrite DI Ltd. Stock Analysis: 5-Day Bearish Momentum Insights

Cellebrite DI Ltd. (CLBT) stock has crashed to $10.22 following a post-earnings decline, placing it deep in oversold territory according to its RSI readings across multiple timeframes. The company missed annual recurring revenue expectations due to delayed transactions and slower customer migration gains, leading …

Cerebras Systems Poised to See More Upside From Capacity, AI Demand, Morgan Stanley Says

Cerebras Systems (CBRS) is poised to see further growth as it adds data center capacity, expands new inference products with AMD (AMD) and Amazon (AMZN) Web Services, as well as gains more hyperscaler business, Morgan Stanley said in a note Thursday.The company expects core …

Birkenstock Rallies on Forecast; StubHub Falls on Earnings | Stock Movers

On this episode of Stock Movers:- StubHub (STUB) shares are dropping after the company reported earnings per share for the second quarter that missed the average analyst estimate. - Birkenstock (BIRK) is rallying after the footwear maker boosted its adjusted Ebitda forecast for the …

Cerebras stock falls on earnings disappointment despite guidance raise

Cerebras Systems Inc (NASDAQ:CBRS) shares fell 11% Thursday after the AI chipmaker reported second-quarter revenue below Wall Street estimates, even as the company raised its full-year guidance. The company posted second-quarter revenue of $180.1 million, missing the $194 million analyst estimate, though up 74% …

Cerebras Systems (NASDAQ:CBRS) Shares Gap Down Following Weak Earnings

Cellebrite DI (NASDAQ:CLBT) Sets New 52-Week Low - Time to Sell?

Cellebrite DI (NASDAQ:CLBT) shares recently fell to a new 52-week low of $10.55, despite previously closing at $15.25. While insider selling totaling $2.48 million occurred over the last three months, analysts maintain a "Moderate Buy" consensus with an average price target of $21.80. Institutional …

Cellebrite DI Q2 Earnings Call Highlights

Cerebras Systems Ord Shs Class A (Proposed) Stock (CBRS) Opened Down by 11.55% on Aug 13: Key Drivers Unveiled

Cerebras Systems (CBRS) stock opened down by 11.55% on August 13th following a miss on second-quarter revenue expectations and continued net losses. Infrastructure constraints, hardware sales slowdown, and high research and development expenditures contributed to the sell-off. Despite these challenges, analysts maintain a constructive …

Cerebras Shares Tumble After Growth Underwhelms Investors

Cerebras Systems Stock Plummets on Revenue Miss

Nvidia rival Cerebras stock plunges as company swings to quarterly loss

What happened: Cerebras Systems (CBRS) stock fell 17% in premarket trading on Thursday after the AI chipmaker's Q2 results and Q3 outlook failed to impress investors a day earlier. What's behind the move: Cerebras swung to a loss of $2.98 per share in Q2 …

Cellebrite Appoints Shiven Ramji CEO as Company Sharpens Product Strategy

Cellebrite DI Ltd. has appointed Shiven Ramji as its new CEO, succeeding Thomas E. Hogan, to sharpen its product strategy with a focus on AI and new growth opportunities. Ramji, previously president of products and technology, will lead the company's expansion beyond digital forensics …